Posted in | News | Laser | Optics and Photonics

BluGlass Launches Six Laser Products at Photonics West

Global semiconductor developer BluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass’ lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-mode devices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts.

Image Credit: BluGlass Limited

BluGlass’ suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing.

The following products are now available for customer purchase:

  • Violet 405 nm multi-mode 1W laser
  • Violet 405 nm single-mode 250mW laser
  • Violet 420 nm multi-mode 1W laser
  • Violet 420 nm single-mode 250mW laser
  • Blue 450 nm multi-mode 1W laser
  • Blue 450 nm single-mode 100mW laser

The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry.

Commenting on the product launches, BluGlass President Jim Haden said, “We are delighted to launch our first suite of products at Photonics West. The release of these laser diodes reflects the significant performance and reliability improvements we have made over the past year. The market is telling us there is a growing need for a dedicated GaN laser supplier who can provide greater manufacturing agility and form factor flexibility, to enable manufacturers to expand their product offerings and market applications. We have several potential customers interested in our portfolio, and this significant milestone paves the way for first orders and commercial revenues.

“Our product offering will continue to grow and improve - with expanded wavelengths, higher-power, and novel laser architectures also progressing through the supply chain. We expect the execution of our ongoing vertical integration plans to further improve quality and accelerate development timelines for future products and enable us to scale manufacturing capacity to meet demand.

“The visible laser market is a high-value and high-margin semiconductor segment that is growing rapidly, with ubiquitous use in everything from consumer electronics, advanced manufacturing to medical diagnostics, quantum computing, and defense applications. Within the broader market, GaN lasers offer inherent advantages over traditional infrared laser diodes, including higher energy absorption in key industrial metals, tighter beam focus, and improved efficiency. These competitive advantages are driving significant interest from global customers.”

In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass’ supply chain, including RPCVD-enhanced products.

This announcement has been approved for release by the BluGlass Board.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BluGlass. (2023, January 30). BluGlass Launches Six Laser Products at Photonics West. AZoOptics. Retrieved on July 23, 2024 from

  • MLA

    BluGlass. "BluGlass Launches Six Laser Products at Photonics West". AZoOptics. 23 July 2024. <>.

  • Chicago

    BluGlass. "BluGlass Launches Six Laser Products at Photonics West". AZoOptics. (accessed July 23, 2024).

  • Harvard

    BluGlass. 2023. BluGlass Launches Six Laser Products at Photonics West. AZoOptics, viewed 23 July 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.